Evidence map›Paper›PMID 33104091›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2020

Three sequential outbreaks of Group A

Barbara Strauss, Martin Tepper, Diane Lu, François Gagnon, Eric Girard, Walter Demczuk, Irene Martin, Martine Massé, Kirsten Barnes

Abstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Barbara StraussDirectorate Force Health Protection, Canadian Forces Health Services, Ottawa, ON.
Martin TepperDirectorate Force Health Protection, Canadian Forces Health Services, Ottawa, ON.
Diane LuDirectorate Force Health Protection, Canadian Forces Health Services, Ottawa, ON.
François Gagnon41 Centre des Services de santé des Forces canadiennes, Richelain, QC.
Eric Girard41 Centre des Services de santé des Forces canadiennes, Richelain, QC.
Walter DemczukNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Irene MartinNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Martine Massé41 Centre des Services de santé des Forces canadiennes, Richelain, QC.
Kirsten BarnesDirectorate Force Health Protection, Canadian Forces Health Services, Ottawa, ON.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince December 2016, the basic military training (BMT) facility for the Canadian Armed Forces (CAF) has experienced repeated outbreaks of Group A

methodsDescriptive data were collected on invasive and severe GAS cases along with laboratory data including genotyping of throat swabs from recruits presenting with pharyngitis. A laboratory-based acute respiratory infection surveillance system was used to aid in monitoring and decision-making. Close contacts of recruits were assessed for asymptomatic GAS carriage and MAP adverse events surveillance was conducted.

resultsThree distinct GAS outbreaks occurred at the Canadian Forces Leadership and Recruit School totaling eight invasive (iGAS) and 13 severe (sGAS) cases over two years. All iGAS/sGAS cases, apart from one instructor, were among recruits. The predominant strain in all three outbreaks was type

conclusionThe CAF BMT facility experienced three GAS outbreaks over the course of two years, and despite the use of enhanced hygiene measures, only MAP has been effective in quelling these outbreaks.

Indexed as

Canadainfectious disease outbreaksmass antibiotic prophylaxismilitary recruitsStreptococcus pyogenes

Identifiers

PMID33104091
PMCPMC7556203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.